Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9139653 Anti-human OX40L antibodies and methods of treatment

Patent 9139653 was granted and assigned to Kymab on September, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Kymab

Current Assignee

Kymab

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9139653

Date of Patent

September 22, 2015

Patent Application Number

14700896

Date Filed

April 30, 2015

Patent Citations Received

‌

US Patent 11786529 Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors

‌

US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies

‌

US Patent 11773175 Antibodies, uses and methods

‌

US Patent 11779604 Antibodies, combinations comprising antibodies, biomarkers, uses and methods

‌

US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors

Patent Primary Examiner

‌

Ilia Ouspenski

Patent abstract

The present invention relates to anti-human OX40L antibodies, new medical uses and methods.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9139653 Anti-human OX40L antibodies and methods of treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API